[Retracted] Antidiabetic Effect of Tamarindus indica and Momordica charantia and Downregulation of TET-1 Gene Expression by Saroglitazar in Glucose Feed Adipocytes and Their Involvement in the Type 2 Diabetes-Associated Inflammation In Vitro

Table 2

Effect of aqueous seed extract of Tamarindus indica and Momordica charantia after 7 days and 14 days of treatment on glucose level in diabetic adipocytes (mean ± S.E.M.).

Group	Glucose level (mg/dl)
	At the time of grouping		Days of supplements
		0 day	7 days	14 days
Control adipocytes	87.4 ± 7.8	88.2 ± 8.6	84.3 ± 7.4	84.2 ± 7.6
Diabetic adipocytes	85.4 ± 8.1	352.3 ± 11.2	336.4 ± 10.8	328.8 ± 10.6
Tamarindus indica supp.	86.1 ± 10.2	365.9 ± 11.9	121.4 ± 9.2	88.2 ± 12.4
Momordica charantia supp.	86.8 ± 9.7	371.2 ± 13.5	130.8 ± 8.4	87.6 ± 9.8

ANOVA followed by multiple two-tailed -tests. In each vertical column, mean with an asterisk () differs significantly from control or diabetic adipocytes ().